Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer

BACKGROUND: Limited therapeutic options are available for triple-negative breast cancer (TNBC), emphasizing an urgent need for more effective treatment approaches. The development of strategies by targeting tumor-associated macrophages (TAMs) to stimulate their ability of Programmed Cell Removal (Pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Xu, Li, Bolei, Chen, Jing, Dang, Jessica, Chen, Siqi, Gunes, E Gulsen, Xu, Bo, Tian, Lei, Muend, Sabina, Raoof, Mustafa, Querfeld, Christiane, Yu, Jianhua, Rosen, Steven T., Wang, Yingyu, Feng, Mingye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986678/
https://www.ncbi.nlm.nih.gov/pubmed/33753567
http://dx.doi.org/10.1136/jitc-2020-002022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986678/
https://www.ncbi.nlm.nih.gov/pubmed/33753567
http://dx.doi.org/10.1136/jitc-2020-002022

Ejemplares similares